The effect of alendronate on lipid profile of postmenopausal women with osteopenia and prediabetes: A randomized triple-blind clinical trial

BACKGROUND: Prediabetes is a high-risk state for developing diabetes at an annual rate of 5%–10%. Early intervention can prevent further complications, including metabolic syndrome. Bisphosphonates are commonly used for osteoporotic postmenopausal women. The purpose of this study was to assess the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimifard, Maryam, Aminorroaya, Ashraf, Amini, Massoud, Kachuie, Ali, Feizi, Awat, Yamini, Sima Aminorroaya, Alijanvand, Moluk Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506247/
https://www.ncbi.nlm.nih.gov/pubmed/34729060
http://dx.doi.org/10.4103/jrms.JRMS_579_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506247/
https://www.ncbi.nlm.nih.gov/pubmed/34729060
http://dx.doi.org/10.4103/jrms.JRMS_579_19

Ejemplares similares